Skip to content

Gastrointestinal Decompression in Stroke

Safety and Efficacy of Early Gastrointestinal Decompression for Patients With Acute Severe Ischemic Stroke

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06214091
Acronym
EAGER-ASSIST
Enrollment
60
Registered
2024-01-19
Start date
2024-02-01
Completion date
2025-07-01
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal Decompression, Pulmonary Infection, Stomach Acidity, Stroke

Brief summary

Acute severe ischemic stroke is a life-threatening subtype of stroke. Due to stress ulcer and gastric reflux in acute stage, patients with severe ischemic stroke are always complicated with stomach bleeding and pulmonary infections, resulting in poor prognosis and even death. Reducing stomach acidity and avoiding gastric reflux play a pivotal role on controlling serious complications after austere ischemic attack. Gastrointestinal decompression is an cheap, safe, effective and acknowledgemented strategy for treating stomach bleeding and preventing gastric reflux in clinical settings. Early gastrointestinal decompression seems to be an available method to reduce stomach acidity and avoid gastric reflux after severe ischemic stroke. Therefore, we aimed to evaluate the safety and efficacy of early gastrointestinal decompression in patients with acute severe ischemic stroke.

Interventions

PROCEDUREGastrointestinal decompression

Gastric tube is inserted within 24-hour severe ischemic stroke attack; gastrointestinal decompression is performed for 48 hours.

PROCEDUREControl

Gastric tube is inserted within 24-hour severe ischemic stroke attack.

Sponsors

Tianjin Medical University General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Age 18-80 years * severe AIS, including NIHSS score\>20 in dominant hemisphere infarction, or NIHSS score\>15 in non-dominant hemisphere infarction, or NIHSS consciousness score \>1; · massive infarction, characterized by infarction area larger than 1/3 of the effected middle cerebral artery territory and/or the cerebellum territory presented in admitted computed tomography (CT) or MRI * onset-to-needle time within 24 hours * prestroke modified Ranking scales (mRS)≤1 * sign the informed consent.

Exclusion criteria

* Recent respiratory infection and/or gastrointestinal bleeding * austere diseases such as tumors and dyscrasia * intention to undergo emergency thrombectomy * pregnant women or nursing mother * contraindication for gastric tubes * participating in other clinical trials within previous 3 months.

Design outcomes

Primary

MeasureTime frameDescription
90-day Death90 daysDeath rate at 90 days

Secondary

MeasureTime frameDescription
90-day mRS90 daysmRS at 90 days
90-day Barthel scores90 daysBarthel scores at 90 days
30-day mRS30 daysmRS at 30 days
30-day Barthel scores30 daysBarthel scores at 30 days

Contacts

Primary ContactJiayue Ding
sjnkzz2@163.com+8618518347837

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026